0001610618-24-000025.txt : 20240320
0001610618-24-000025.hdr.sgml : 20240320
20240320184741
ACCESSION NUMBER: 0001610618-24-000025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240320
DATE AS OF CHANGE: 20240320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tari Leslie
CENTRAL INDEX KEY: 0001870270
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 24768982
MAIL ADDRESS:
STREET 1: C/O CIDARA THERAPEUTICS, INC.
STREET 2: 6310 NANCY RIDGE DR SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cidara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001610618
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 461537286
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-752-6170
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: K2 THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140611
4
1
wk-form4_1710974846.xml
FORM 4
X0508
4
2024-03-15
0
0001610618
Cidara Therapeutics, Inc.
CDTX
0001870270
Tari Leslie
6310 NANCY RIDGE DRIVE
SUITE 101
SAN DIEGO
CA
92121
0
1
0
0
CHIEF SCIENTIFIC OFFICER
0
Common Stock
2024-03-15
4
A
0
111250
0
A
369931
D
Common Stock
1484
I
By spouse
Employee Stock Option (right to buy)
0.6849
2024-03-15
4
A
0
222500
0
A
2034-03-14
Common Stock
222500
222500
D
Represents time-based Restricted Stock Units (RSUs) granted on March 15, 2024. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2025, 2026, and 2027, subject to continuous service through each such vesting date.
The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 15, 2024.
/s/ Shane Ward, Attorney-in-Fact
2024-03-20